| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $95.7M | -60.7% |
| Gross Profit | -$39.4M | -300.7% |
| R&D Expense | $3.9M | -3.2% |
| SG&A Expense | $9.7M | +4.5% |
| Operating Income | -$53.0M | -931.6% |
| Pre-tax Income | -$49.2M | -402.1% |
| Income Tax | $165K | -79.2% |
| Net Income | -$49.4M | -418.6% |
| EPS (Basic) | -$1.13 | -422.9% |
| EPS (Diluted) | -$1.13 | -422.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $51.3M | -53.2% |
| Accounts Receivable | $9.4M | -57.0% |
| Inventory | $21.3M | +3.0% |
| Current Assets | $100.5M | -39.0% |
| Total Assets | $192.2M | -22.4% |
| Current Liabilities | $17.7M | -46.7% |
| Total Liabilities | $37.5M | -10.4% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.7M | -215.9% |
| Capital Expenditures | $17.2M | +17.6% |
| Investing Cash Flow | -$18.6M | -25.7% |
| Financing Cash Flow | -$10.9M | +90.9% |
| Free Cash Flow | -$46.0M | -553.7% |
| $154.7M |
| -24.8% |